Comparative disribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor MRNAs in the rat brain during development

Journal of Comparative Neurology

Volumn 425, Issue 4, 2000, Pages 495-509

  Basille, Magali ^a   Vaudry, David ^a   Coulouarn, Yolaine ^a   Jegou, Sylvie ^a   Lihrmann, Isabelle ^a   Fournier, Alain ^b   Vaudry, Hubert ^a   Gonzalez, Bruno ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

In situ hybridization; Neuropeptides; Ontogeny; Pituitary adenylate cyclase activating polypeptide receptor 1; Receptor binding; Vasoactive intestinal polypeptide pituitary adenylate cyclase activating polypeptide receptors 1 and 2

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; ADCYAP1 PROTEIN, RAT; ADCYAP1R1 PROTEIN, RAT; HORMONE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; VIPR1 PROTEIN, RAT; VIPR2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN DEVELOPMENT; FEMALE; FETUS; MALE; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NEUROEPITHELIUM; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; AGING; ANIMAL; AUTORADIOGRAPHY; BRAIN; COMPARATIVE STUDY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IN SITU HYBRIDIZATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WISTAR RAT;

AGING; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; IN SITU HYBRIDIZATION; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0034596587     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20001002)425:4<495::AID-CNE3>3.0.CO;2-A     Document Type: Article

References (55)

1. Postnatal development of the cerebellar cortex in the rat. II. Phases in the maturation of Purkinje cells and of the molecular layer
2. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems
3. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligode-oxynucleotides
4. SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival
5. Suppression of tumorigenicity of neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1
6. Localization and characterization of PACAP receptors in the rat cerebellum during development. Evidence for a stimulatory effect of PACAP on immature cerebellar granule cells
7. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: A quantitative autoradiographic study
8. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts
9. Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei
10. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway
11. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord
14. Somatostatin receptors are expressed by immature cerebellar granule cells: Evidence for a direct inhibitory effect of somatostatin on neuroblast activity
15. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts
16. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors
17. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain
18. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives
19. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
20. Pituitary adenylate cyclase-activating peptide phase shifts circadian rhythms in a manner similar to light
21. Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth
22. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
23. Histogenesis and morphogenesis of cortical structures
24. Juvenile mortality and decreased female fertility in the PAC1 receptor null mice
25. Differential alteration of hippocampal synaptic strength induced by pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38)
26. Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells
27. Inhibition of human neuroblastoma growth by a specific VIP antagonist
28. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro
29. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells
30. Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms
31. The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
32. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) and its binding sites in the rat brain
33. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
34. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex
35. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei
36. Genomic structure and embryonic expression of the rat type 1 vasoactive intestinal polypeptide receptor gene
37. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones
38. Acute effects of antisense antagonism of a single peptide neurotransmitter in the circadian clock
39. Expression of pituitary adenylate cyclase activating polypeptide receptors in the early mouse embryo as assessed by reverse transcription polymerase chain reaction and in situ hybridisation
40. Expression of PACAP, and PACAP type 1 (PAC1) receptor mRNA during development of the mouse embryo
41. Temporal profiles of vasoactive intestinal polypeptide precursor mRNA and its receptor mRNA in the rat suprachiasmatic nucleus
42. Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain
43. Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain
44. Differential signal transduction by five splice variants of the PACAP receptor
45. Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain
46. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
47. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway
48. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development
49. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions
50. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain
51. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway
52. Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines
53. Neural tube expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and receptor: Potential role in patterning and neurogenesis
54. Vasoactive intestinal peptide: A growth promoter in neuroblastoma cells
55. Pituitary adenylate cyclase-activating polypeptide receptors during development: Expression in the rat embryo at primitive streak stage